The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCML Microcircuits Regulatory News (CML)

Share Price Information for CML Microcircuits (CML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 385.00
Bid: 380.00
Ask: 390.00
Change: 20.00 (5.48%)
Spread: 10.00 (2.632%)
Open: 365.00
High: 385.00
Low: 365.00
Prev. Close: 365.00
CML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Microwave Technology Inc Acquisition

2 Oct 2023 08:54

RNS Number : 3403O
CML Microsystems PLC
02 October 2023
 

2 October 2023

CML Microsystems Plc

("CML", the "Company" or the "Group") 

Completion of Microwave Technology, Inc Acquisition

CML, which develops mixed-signal, RF and microwave semiconductors for global communications markets, is pleased to announce that it has, today, completed the acquisition of Microwave Technology, Inc. ("MwT") (the "Acquisition").

Background to Microwave Technology, Inc.

Founded in 1982, MwT is a recognised leader in the design, manufacturing and marketing of GaAs and GaN Based MMICs, Discrete Devices, and Hybrid Amplifier Products for Commercial Wireless Communication, Defence, Space, and Medical (MRI) applications. It became part of the IXYS Corporation, which was then acquired in 2018 by Littelfuse, Inc., the global technology manufacturing company headquartered in Chicago. In 2019, MwT undertook a management buy-out from Littelfuse, at the same time transitioning away from manufacturing to a fabless semiconductor model with a specific focus on MMICs. The business currently consists of 20 employees and operates from Fremont, California.

The Acquisition

The Acquisition expands the Group's product portfolio, strengthens and enhances its support resources and increase its R&D capabilities, providing essential knowhow and experience in system level understanding, product manufacturing and packaging techniques. MwT's products are complementary to CML's existing offering and the majority of its focus and client concentration is within the USA. The Board of CML believes there is a significant opportunity to increase its current market share by internationalising MwT's products.

The total consideration payable for the Acquisition is $13.18m, of which $7.65m is payable in cash and $5.53m is payable in shares. The cash element, which is subject to customary post-completion adjustments, is payable in four tranches; with $1.93m payable on completion, $1.17m payable on the six-month anniversary of completion, $2.65m payable on the first anniversary of completion and $1.90m payable on the second anniversary of completion (with the latter three payments being subject to performance related adjustments). The $5.53m share element of the consideration is payable via the issue to the sellers of 864,349 new CML ordinary shares of 5 pence each ("Ordinary Shares"), valued at a price of 440 pence per share, being the volume-weighted average price of CML's shares for the 30 days prior to the initial announcement of the transaction on 17 January 2023, to be issued in three tranches (the "Consideration Shares"). 592,010 Consideration Shares will be issued on completion (the "Initial Consideration Shares"), 90,780 Consideration Shares will be issued on the first anniversary of completion, 90,780 Consideration Shares will be issued on the second anniversary of completion and 90,779 Consideration Shares will be issued on the third anniversary of completion.

Chris Gurry, CML's Group Managing Director commented: "We are delighted to finally welcome MwT into the CML Group. Their dedicated and very experienced team will accelerate our multi-year growth strategy, enhancing the Group's existing competencies, whilst the strong cultural synergies bode well for the combined businesses over the medium term."

MwT's unaudited US GAAP results for the 12-month period to 31 December 2022 recorded revenue of $6.5m and a pre-tax loss of $132k with net assets of circa $2.4m. The Board expects that MwT will be earnings enhancing in its first full year of ownership within CML.

It is intended that Dr. Nathan Zommer, who was previously MwT's majority shareholder and is MwT's current Chairman, will join the CML Board of Directors in a non-executive capacity.

Dr. Zommer's appointment to the Board is subject to completion of normal regulatory due diligence checks. A further announcement confirming his appointment on completion of normal regulatory due diligence checks and disclosing information in respect of Schedule 2(g) of the AIM Rules will be made in due course.

No further information is required to be disclosed as per Schedule 4 in the AIM Rules for Companies.

Total Voting Rights

Application has been made to the London Stock Exchange for the 592,010 Initial Consideration Shares to be admitted to trading on AIM, which is expected to occur on 3 October 2023.

In conformity with the Financial Conduct Authority's Disclosure and Transparency rules, CML Microsystems Plc hereby notifies the market that following the issue of the Initial Consideration Shares, the Company's issued share capital comprises 16,504,754 ordinary shares of 5p each. The total number of treasury shares held is 360,675 which do not carry voting rights.

The total number of voting rights in the Group is therefore 16,144,079 (which excludes ordinary shares held by the Group in treasury).

This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FCA's Disclosure and Transparency Rules.

The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

CML Microsystems Plc

Chris Gurry, Group Managing DirectorNigel Clark, Executive Chairman

 

   Tel: +44(0)1621 875 500

Shore Capital

Toby Gibbs

James Thomas

Lucy Bowden

Fiona Conroy (Corporate Broking)

 

 Tel: +44(0)20 7408 4090 

Alma PR

Josh Royston

Andy Bryant

Matthew Young

 Tel: +44 (0)20 3405 0212

 

 

About CML Microsystems Plc

CML develops mixed-signal, RF and microwave semiconductors for global communications markets. The Group utilises a combination of outsourced manufacturing and in-house testing with trading operations in the UK, Asia and USA. CML targets sub-segments within Communication markets with strong growth profiles and high barriers to entry. It has secured a diverse, blue chip customer base, including some of the world's leading commercial and industrial product manufacturers.

The spread of its customers and diversity of the product range largely protects the business from the cyclicality usually associated with the semiconductor industry. Growth in its end markets is being driven by factors such as the appetite for data to be transmitted faster and more securely, the upgrading of telecoms infrastructure around the world and the growing prevalence of private commercial wireless networks for voice and/or data communications linked to the industrial internet of things (IIoT).

The Group is cash-generative, has no debt and is dividend paying.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQMTBRTMTAMMMJ
Date   Source Headline
9th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20247:00 amRNSBlock listing Interim Return
26th Mar 20247:00 amRNSTrading Update and Notice of Results
20th Dec 202311:27 amRNSAppointment of Non-Executive Director
18th Dec 202310:45 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSHalf Year Results
1st Dec 20237:00 amRNSBoard & Senior Management Appointments
13th Nov 20237:00 amRNSNotice of Results
4th Oct 202310:21 amRNSHolding(s) in Company
4th Oct 202310:15 amRNSHolding(s) in Company
2nd Oct 20238:54 amRNSCompletion of Microwave Technology Inc Acquisition
27th Sep 202311:40 amRNSBlock Listing Interim Return
26th Sep 202310:47 amRNSUS Government Clearance for MwT Acquisition
9th Aug 20233:22 pmRNSResult of AGM
9th Aug 202311:00 amRNSAGM Statement
29th Jun 20237:00 amRNSDirector/PDMR Dealing
27th Jun 20237:00 amRNSFull Year Results
26th Apr 20233:40 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSCompletion of Share Buyback Programme
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20231:02 pmRNSUpdate to Share Buyback Programme
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20238:39 amRNSTransaction in Own Shares
11th Apr 20231:58 pmRNSHolding(s) in Company
11th Apr 202311:36 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 202310:35 amRNSShare Buyback Programme
27th Mar 202312:35 pmRNSBlock Listing Interim Return
27th Mar 20237:00 amRNSTrading Update and Notice of Results
21st Mar 20237:00 amRNSDirector/PDMR Dealing
3rd Mar 20237:00 amRNSDirector/PDMR Dealing
17th Feb 20237:00 amRNSOval Park Planning Progress
18th Jan 20237:30 amRNSShare Buyback Programme Update
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSAcquisition of Microwave Technology, Inc.
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
22nd Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:00 amRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20227:00 amRNSTransaction in Own Shares
6th Dec 20227:00 amRNSTransaction in Own Shares
5th Dec 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.